Project Details
Description
Discovery and development of OGG1 activators as precision drugs for modification of Alzheimer?s disease progression
| Status | Active |
|---|---|
| Effective start/end date | 7/1/23 → 6/30/24 |
Funding
- LUCIOLE PHARMACEUTICALS, INC.
- NATIONAL INSTITUTES OF HEALTH (NIH)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.